Case Report

Published on 09 Jul 2024

Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma

in Cancer Molecular Targets and Therapeutics

Liquan Zhu
Haoqiang Wang
Donghai Cheng
Wei Wang
Yue Lei
Ning Yang
Lijun Peng
Peng Liu
Juan Zhou
Bo Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1382376

741 views
1 citation

Editorial

Published on 05 Jul 2024

Editorial: The MACC1 network in cancer

in Cancer Molecular Targets and Therapeutics

Wolfgang Walther
Franziska Siegel
Ulrike Stein

Frontiers in Oncology

doi 10.3389/fonc.2023.1343812

780 views

Perspective

Published on 04 Jul 2024

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

in Cancer Molecular Targets and Therapeutics

Nam Phong Nguyen
Ulf Lennart Karlsson
Brandi R. Page
Monica-Emilia Chirila
Vincent Vinh-Hung
Olena Gorobets
Meritxell Arenas
Mohammad Mohammadianpanah
Seyed Alireza Javadinia
Huan Giap

Frontiers in Oncology

doi 10.3389/fonc.2024.1371752

1,695 views

Original Research

Published on 01 Jul 2024

Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer

in Cancer Molecular Targets and Therapeutics

Feifan Xiang
Yue Zhang
Xiaoqi Tan
Jintao Zhang
Tengfei Li
Yuanzhuo Yan
Wenzhe Ma
Yue Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1413771

1,156 views

Original Research

Published on 01 Jul 2024

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells

in Cancer Molecular Targets and Therapeutics

Aurora Costa
Iris Maria Forte
Francesca Pentimalli
Carmelina Antonella Iannuzzi
Luigi Alfano
Francesca Capone
Rosa Camerlingo
Alessandra Calabrese
Claudia von Arx
Reyes Benot Dominguez

Frontiers in Oncology

doi 10.3389/fonc.2024.1418951

1,259 views

Review

Published on 24 Jun 2024

Assessment of KRASG12C inhibitors for colorectal cancer

in Cancer Molecular Targets and Therapeutics

Gary A. Piazza
Preethi Chandrasekaran
Yulia Y. Maxuitenko
Karim I. Budhwani

Frontiers in Oncology

doi 10.3389/fonc.2024.1412435

2,290 views
1 citation

Mini Review

Published on 17 Jun 2024

Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature

in Cancer Molecular Targets and Therapeutics

Shuo Wu
Chenxi Hu
Kaiyuan Hui
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1408051

1,167 views

Review

Published on 12 Jun 2024

MUC21: a new target for tumor treatment

in Cancer Molecular Targets and Therapeutics

Miao Li
Hui Li
Ting Yuan
Zhi Liu
Yukun Li
Yingzheng Tan
Yunzhu Long

Frontiers in Oncology

doi 10.3389/fonc.2024.1410761

1,845 views

Case Report

Published on 12 Jun 2024

Case report: Innovative treatment for one metastatic thyroid-like follicular carcinoma of the kidney with ATM and POLE mutations

in Cancer Molecular Targets and Therapeutics

Jin-Ju Lei
Jie Rao
Hong-Yan Feng
De-Dong Cao
Hong-Lin Yan
Jing-Ping Yuan
Zhen-Min Jiang
Yi-Qiao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1352865

967 views

Original Research

Published on 12 Jun 2024

Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells

in Cancer Molecular Targets and Therapeutics

Joseph A. Haight
Stacia L. Koppenhafer
Elizabeth L. Geary
David J. Gordon

Frontiers in Oncology

doi 10.3389/fonc.2024.1394653

873 views

Editorial

Published on 11 Jun 2024

Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?

in Cancer Molecular Targets and Therapeutics

Marina Pinheiro
Qingxin Mu

Frontiers in Oncology

doi 10.3389/fonc.2024.1437497

467 views

Case Report

Published on 10 Jun 2024

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden

in Cancer Molecular Targets and Therapeutics

Rebekka Mispelbaum
Tessa Hattenhauer
Franz-Georg Bauernfeind
Jan-Frederic Lau
Peter Brossart
Annkristin Heine

Frontiers in Oncology

doi 10.3389/fonc.2024.1406616

716 views
1 citation

Brief Research Report

Published on 30 May 2024

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

in Cancer Molecular Targets and Therapeutics

Andrew Takchi
Minzhi Zhang
Mohammad Jalalirad
Roberto Leon Ferre
Royal Shrestha
Tufia Haddad
Jann Sarkaria
Ann Tuma
Jodi Carter
Hillman David

Frontiers in Oncology

doi 10.3389/fonc.2024.1384277

1,684 views

Review

Published on 28 May 2024

Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies

in Cancer Molecular Targets and Therapeutics

Nating Xiong
Heming Wu
Zhikang Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1405491

4,252 views
4 citations

Mini Review

Published on 28 May 2024

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

in Cancer Molecular Targets and Therapeutics

Fengqin Liu
Xia Miao
Lu Han
Xiao Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1390006

2,122 views
1 citation

Perspective

Published on 24 May 2024

Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group

in Cancer Molecular Targets and Therapeutics

Nam P. Nguyen
Monica-Emilia Chirila
Brandi R. Page
Vincent Vinh-Hung
Olena Gorobets
Mohammad Mohammadianpanah
Huan Giap
Meritxell Arenas
Marta Bonet
Pedro Carlos Lara

Frontiers in Oncology

doi 10.3389/fonc.2024.1391464

1,554 views

Navigation group

Articles

Case report: Pyrotinib in the treatment of advanced scrotal EMPD combined with sweat gland carcinoma

Editorial: The MACC1 network in cancer

Immunotherapy and radiotherapy for older patients with invasive bladder cancer unfit for surgery or chemotherapy: practical proposal by the international geriatric radiotherapy group

Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer

Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells

Assessment of KRASG12C inhibitors for colorectal cancer

Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature

MUC21: a new target for tumor treatment

Case report: Innovative treatment for one metastatic thyroid-like follicular carcinoma of the kidney with ATM and POLE mutations

Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells

Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?

Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group